Based in South Africa, Aspen are Africa's largest pharmaceutical manufacturer, and the ninth largest pharmaceutical company in the world. Aspen has businesses in Australia, India, South Africa, the United Kingdom and a start-up operation in the United States. Products available in more than 150 countries. GlaxoSmithKline acquired a 19% stake in 2009, which it reduced to 12% in 2013, and further reduced to 6% in 2015.
|Aspen Pharmacare Holdings Ltd||ZAF||website|
|Aspen Pharmacare Holdings Ltd|
This company is named and shamed in IBFAN's 2017 report, 'Breaking the Rules, Stretching the Rules 2017', evidence of violations of the International Code of Marketing of Breastmilk Substitutes, compiled from June 2014 to June 2017. The report covers 792 Code violations from 79 countries and by 28 companies.
[Source 2017][More on Irresponsible Marketing]
Follow the link to view relevant documents which support this company's sustainability claims.
[Source 2015][More on Sustainability Reporting]
The United Nations Global Compact asks companies to embrace, support and enact, within their sphere of influence, a set of 10 values in the areas of human rights, labour standards, the environment, and anti-corruption. However it's non-binding nature has been widely criticised, and many signatory corporations continue to violate the Compact's values.
[Source 2013][More on Sustainability Reporting]
|Company Structure||Public company|
|Revenue||US$2.8 billion in 2014|
|# Employees||8,200 in 2014|
|Subsidiaries||Aspen Asia Pacific Pty Ltd|
|Address||Johannesburg, South Africa|